Join
Live feed
·
INSIDERFilingvia Quantisnow
OnKure Therapeutics Inc. logo

President and CEO Saccomano Nicholas A sold $378 worth of shares (86 units at $4.40), decreasing direct ownership by 0.76% to 11,247 units (SEC Form 4) (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
OKUR· OnKure Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OKUR (OnKure Therapeutics Inc.) and more on Quantisnow.